Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 5 | 2024 | 1188 | 2.270 |
Why?
|
Fentanyl | 5 | 2024 | 434 | 1.740 |
Why?
|
Substance Abuse Detection | 3 | 2024 | 301 | 1.090 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2024 | 32 | 0.910 |
Why?
|
Chromatography, Liquid | 5 | 2024 | 983 | 0.780 |
Why?
|
Ceruloplasmin | 1 | 2020 | 56 | 0.730 |
Why?
|
Iron Metabolism Disorders | 1 | 2020 | 24 | 0.730 |
Why?
|
Immunoassay | 2 | 2024 | 745 | 0.700 |
Why?
|
Acidosis, Lactic | 1 | 2021 | 146 | 0.670 |
Why?
|
Bupivacaine | 1 | 2022 | 412 | 0.630 |
Why?
|
Heart Neoplasms | 1 | 2022 | 362 | 0.620 |
Why?
|
Paraproteinemias | 1 | 2020 | 248 | 0.570 |
Why?
|
Methadone | 1 | 2019 | 321 | 0.560 |
Why?
|
Ischemic Attack, Transient | 1 | 2022 | 882 | 0.540 |
Why?
|
Medical Order Entry Systems | 1 | 2020 | 521 | 0.470 |
Why?
|
Cost Savings | 1 | 2020 | 913 | 0.470 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1027 | 0.460 |
Why?
|
Arabidopsis Proteins | 1 | 2016 | 264 | 0.460 |
Why?
|
Buprenorphine | 1 | 2022 | 656 | 0.450 |
Why?
|
Paraproteins | 1 | 2013 | 38 | 0.430 |
Why?
|
Metformin | 1 | 2021 | 906 | 0.430 |
Why?
|
Limit of Detection | 2 | 2024 | 273 | 0.400 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3826 | 0.390 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2017 | 1897 | 0.390 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1087 | 0.380 |
Why?
|
Myeloma Proteins | 1 | 2010 | 71 | 0.370 |
Why?
|
Decision Support Systems, Clinical | 1 | 2020 | 1175 | 0.360 |
Why?
|
False Positive Reactions | 2 | 2024 | 957 | 0.330 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1924 | 0.320 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 3085 | 0.310 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2020 | 2872 | 0.300 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2013 | 1073 | 0.280 |
Why?
|
Cannabis | 2 | 2023 | 441 | 0.260 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3415 | 0.260 |
Why?
|
DNA-Directed DNA Polymerase | 2 | 2007 | 489 | 0.240 |
Why?
|
Catalytic Domain | 3 | 2017 | 705 | 0.240 |
Why?
|
Prothrombin Time | 1 | 2024 | 117 | 0.220 |
Why?
|
Partial Thromboplastin Time | 1 | 2024 | 204 | 0.210 |
Why?
|
Indicators and Reagents | 1 | 2024 | 462 | 0.210 |
Why?
|
Blood Coagulation Tests | 1 | 2024 | 271 | 0.210 |
Why?
|
Cannabinoids | 1 | 2023 | 172 | 0.180 |
Why?
|
Chelation Therapy | 1 | 2020 | 77 | 0.180 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2020 | 139 | 0.170 |
Why?
|
Urinalysis | 1 | 2021 | 368 | 0.160 |
Why?
|
Analgesia, Epidural | 1 | 2022 | 332 | 0.160 |
Why?
|
Labor, Obstetric | 1 | 2022 | 323 | 0.160 |
Why?
|
Naloxone | 1 | 2022 | 370 | 0.160 |
Why?
|
Unconsciousness | 1 | 2020 | 250 | 0.160 |
Why?
|
Hallucinogens | 1 | 2021 | 197 | 0.150 |
Why?
|
Nausea | 1 | 2021 | 679 | 0.150 |
Why?
|
Immunoglobulin M | 2 | 2013 | 1527 | 0.150 |
Why?
|
Ferritins | 1 | 2020 | 598 | 0.150 |
Why?
|
Models, Molecular | 4 | 2017 | 5439 | 0.150 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3808 | 0.150 |
Why?
|
Substrate Specificity | 4 | 2017 | 1791 | 0.140 |
Why?
|
Efficiency | 1 | 2020 | 476 | 0.140 |
Why?
|
Humans | 29 | 2024 | 761504 | 0.130 |
Why?
|
Endopeptidases | 4 | 2002 | 774 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12974 | 0.130 |
Why?
|
Creatinine | 1 | 2021 | 1899 | 0.130 |
Why?
|
Molecular Structure | 1 | 2019 | 1880 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1318 | 0.120 |
Why?
|
Peptide Fragments | 5 | 2016 | 5112 | 0.110 |
Why?
|
Mitral Valve | 1 | 2022 | 1465 | 0.110 |
Why?
|
Electrophoresis | 1 | 2013 | 227 | 0.110 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5146 | 0.100 |
Why?
|
Arabidopsis | 1 | 2016 | 465 | 0.100 |
Why?
|
Amyloid beta-Protein Precursor | 4 | 2002 | 1111 | 0.100 |
Why?
|
Protein Binding | 4 | 2020 | 9351 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1989 | 0.090 |
Why?
|
Amyloid beta-Peptides | 5 | 2002 | 3839 | 0.090 |
Why?
|
Legislation, Drug | 2 | 2023 | 214 | 0.090 |
Why?
|
Amino Acid Sequence | 8 | 2020 | 13446 | 0.090 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.090 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7879 | 0.090 |
Why?
|
Binding Sites | 3 | 2016 | 6055 | 0.090 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 286 | 0.080 |
Why?
|
Crystallography, X-Ray | 3 | 2017 | 1990 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2020 | 11528 | 0.080 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2017 | 2748 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2024 | 4420 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2013 | 983 | 0.070 |
Why?
|
Peptides | 1 | 2000 | 4358 | 0.070 |
Why?
|
Base Pair Mismatch | 1 | 2007 | 92 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20098 | 0.070 |
Why?
|
Female | 7 | 2024 | 392644 | 0.060 |
Why?
|
Proteins | 1 | 2000 | 6032 | 0.060 |
Why?
|
Colorado | 1 | 2023 | 165 | 0.050 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 2002 | 31 | 0.050 |
Why?
|
Protein Structure, Tertiary | 2 | 2010 | 3792 | 0.050 |
Why?
|
Molecular Sequence Data | 6 | 2007 | 17635 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6403 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2000 | 506 | 0.050 |
Why?
|
Membrane Proteins | 4 | 2002 | 7856 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2825 | 0.040 |
Why?
|
DNA Replication | 1 | 2007 | 1418 | 0.040 |
Why?
|
Middle Aged | 4 | 2024 | 220895 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 177 | 0.040 |
Why?
|
Serum Albumin, Bovine | 1 | 2000 | 321 | 0.040 |
Why?
|
Precipitin Tests | 1 | 2000 | 814 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2020 | 310 | 0.040 |
Why?
|
Transcription Factors, TFII | 1 | 1998 | 62 | 0.040 |
Why?
|
Glucosyltransferases | 1 | 1998 | 96 | 0.040 |
Why?
|
Ethanol | 1 | 2024 | 1324 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12148 | 0.030 |
Why?
|
DNA Damage | 1 | 2007 | 2446 | 0.030 |
Why?
|
Presenilin-1 | 4 | 2002 | 660 | 0.030 |
Why?
|
Heart Failure | 1 | 2021 | 11669 | 0.030 |
Why?
|
Brain | 2 | 2020 | 27112 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3810 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13506 | 0.030 |
Why?
|
Amyloid Precursor Protein Secretases | 4 | 2002 | 620 | 0.030 |
Why?
|
Neisseria gonorrhoeae | 1 | 1998 | 239 | 0.030 |
Why?
|
Postpartum Period | 1 | 2022 | 1173 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5796 | 0.030 |
Why?
|
Adult | 4 | 2024 | 221177 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 2017 | 4174 | 0.030 |
Why?
|
Analgesics | 1 | 2021 | 1070 | 0.030 |
Why?
|
Estradiol | 1 | 2002 | 1937 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 452 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2010 | 3613 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 996 | 0.030 |
Why?
|
Cattle | 1 | 2000 | 3849 | 0.030 |
Why?
|
Blood Protein Electrophoresis | 1 | 2013 | 66 | 0.030 |
Why?
|
Aged | 3 | 2021 | 169289 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36426 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7212 | 0.030 |
Why?
|
Mass Spectrometry | 4 | 2002 | 2192 | 0.030 |
Why?
|
Blotting, Western | 2 | 2010 | 5035 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2180 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29625 | 0.030 |
Why?
|
Boston | 1 | 2024 | 9326 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 80636 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3332 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 1998 | 2206 | 0.020 |
Why?
|
HeLa Cells | 1 | 2017 | 3093 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2002 | 9539 | 0.020 |
Why?
|
Alzheimer Disease | 3 | 2000 | 8599 | 0.020 |
Why?
|
Cell Line | 2 | 2020 | 15601 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5486 | 0.020 |
Why?
|
DNA Primers | 2 | 2007 | 2819 | 0.020 |
Why?
|
Animals | 9 | 2020 | 168459 | 0.020 |
Why?
|
CHO Cells | 2 | 2002 | 1387 | 0.020 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2000 | 311 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 878 | 0.020 |
Why?
|
Histones | 1 | 1998 | 2580 | 0.020 |
Why?
|
Gene Expression | 2 | 2017 | 7581 | 0.020 |
Why?
|
Cricetinae | 2 | 2002 | 2423 | 0.020 |
Why?
|
Male | 2 | 2024 | 360804 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22169 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4369 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4278 | 0.020 |
Why?
|
Pyrimidine Dimers | 1 | 2007 | 18 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6534 | 0.020 |
Why?
|
Base Pairing | 1 | 2007 | 140 | 0.020 |
Why?
|
DNA Adducts | 1 | 2007 | 94 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4580 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7594 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16591 | 0.020 |
Why?
|
Insulin | 1 | 2000 | 6596 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9318 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 1998 | 3847 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 3076 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1720 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2020 | 14414 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8654 | 0.010 |
Why?
|
United States | 2 | 2023 | 72334 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 1229 | 0.010 |
Why?
|
Base Sequence | 3 | 1999 | 12441 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4575 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10194 | 0.010 |
Why?
|
Protein Conformation | 2 | 2002 | 3968 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26198 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2693 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 1998 | 9606 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29874 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5869 | 0.010 |
Why?
|
Ovariectomy | 1 | 2002 | 614 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6374 | 0.010 |
Why?
|
Epitope Mapping | 1 | 2000 | 298 | 0.010 |
Why?
|
Mice | 4 | 2010 | 81525 | 0.010 |
Why?
|
Helix-Turn-Helix Motifs | 1 | 1998 | 14 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2000 | 522 | 0.010 |
Why?
|
Transcription Factors | 1 | 1998 | 12128 | 0.010 |
Why?
|
Gliosis | 1 | 1999 | 245 | 0.010 |
Why?
|
Solubility | 1 | 2000 | 1091 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1998 | 411 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1998 | 455 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54425 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2000 | 1060 | 0.010 |
Why?
|
Hydrolysis | 1 | 1999 | 664 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2010 | 3396 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1999 | 553 | 0.010 |
Why?
|
Phenylalanine | 1 | 1999 | 366 | 0.010 |
Why?
|
Sigma Factor | 1 | 1998 | 176 | 0.010 |
Why?
|
Albumins | 1 | 2000 | 575 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1130 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 544 | 0.010 |
Why?
|
Point Mutation | 1 | 2002 | 1595 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 2561 | 0.010 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 1998 | 367 | 0.010 |
Why?
|
Transgenes | 1 | 1999 | 1010 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1999 | 1693 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1999 | 1900 | 0.010 |
Why?
|
Specimen Handling | 1 | 2000 | 702 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1998 | 815 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1232 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12795 | 0.010 |
Why?
|
Protein Isoforms | 1 | 1999 | 1699 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10445 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5774 | 0.010 |
Why?
|
Temperature | 1 | 2000 | 2226 | 0.010 |
Why?
|
Amyloidosis | 1 | 1999 | 817 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2000 | 9177 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11742 | 0.010 |
Why?
|
DNA, Viral | 1 | 1998 | 2202 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1998 | 3769 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58976 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 64680 | 0.000 |
Why?
|
Mutation | 2 | 2002 | 30052 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1999 | 11076 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14666 | 0.000 |
Why?
|
Age Factors | 1 | 1999 | 18395 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1999 | 18252 | 0.000 |
Why?
|